Company: FLDDW
Filing Date: 2025-08-11
Form Type: 424B3
Source: 0001213900-25-074298
Chunk: 112

Company: Fold Holdings, Inc.
Filing Date: 2025-08-11
Form: 424B3
Chunk 112
---
 to any volume or manner -of-salelimitations by reason of Rule 144 as promulgated by the SEC under the Securities Act. If the registration statement covering the resale of such Advance Shares is not filed or declared effective by certain days set forth in the SZOP RRA (among other things, the “Event Date”), on each such Event Date and on each monthly anniversary of such Event Date thereafter (if not cured by such date) or any pro rata portion thereof, until the applicable Event Date is cured or sixty calendar days after the applicable Event Date, whichever comes first, the Company shall pay to SZOP an amount in cash, as partial liquidated damages, equal to the product of 1% multiplied by the total purchase price of each outstanding Advance Notice; provided, that the maximum aggregate amount payable thereunder shall not exceed 2% of such amount. The filing of the Registration Statement of which this prospectus forms a part satisfies the obligation of the Company under the SZOP RRA to file a registration statement covering the resale of such Advance Shares prior to the Filing Deadline (as defined in the SZOP RRA). The Company has granted SZOP customary indemnification rights in connection with the SZOP RRA, and SZOP has also granted the Company customary indemnification rights in connection with the SZOP RRA. 61 USE OF PROCEEDS This prospectus relates to the shares of our Common Stock that may be offered and resold from time to time by SZOP and Cohen. See “ Plan of Distribution” elsewhere in this prospectus for more information. All of the shares of Common Stock offered by the Selling Stockholders pursuant to this prospectus will be sold by the Selling Shareholders for their respective accounts. We will not receive any of the proceeds from these sales. We may receive up to $250,000,000 in aggregate gross proceeds from sales of shares of our Common Stock we make to SZOP under the Facility. We may choose to sell fewer than $250,000,000 in shares of our Common Stock, or, due to the Exchange Cap and/or the Beneficial Ownership Cap, we may not be able to sell all $250,000,000 in shares of our Common Stock under the Facility, in which case we would raise less than $250,000,000 in aggregate gross proceeds under the Facility. It is also possible that we do not sell any shares of our Common Stock under the Facility. We did not and will not receive any proceeds from the issuance of Placement Shares to Cohen.